Immunogenicity and safety in healthy adults of full dose versus half doses of #COVID19 #vaccine (#ChAdOx1-S or #BNT162b2) or full-dose #CoronaVac administered as a #booster dose after priming with CoronaVac: a randomised, observer-masked, controlled trial in #Indonesia https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(22)00800-3/fulltext?rss=yes
van Doremalen, N., Avanzato, V.A., Goldin, K. et al. #ChAdOx1 NiV #vaccination protects against lethal #Nipah #Bangladesh virus infection in African green #monkeys. npj Vaccines 7, 171 (2022). https://doi.org/10.1038/s41541-022-00592-9
Kirsebom, F.C.M., Andrews, N., Sachdeva, R. et al. Effectiveness of #ChAdOx1-S #COVID19 #booster #vaccination against the #Omicron and #Delta variants in #England. Nat Commun 13, 7688 (2022). https://doi.org/10.1038/s41467-022-35168-7

Some clarifications:

“SII CEO Adar Poonawalla Exclusive On Covishield Vaccine Pricing, Production & Much More”, CNBC TV18 (https://youtu.be/1b9eRoIJFog).

#COVID19 #CoronaVirus #Vaccine #CoviShield #AstraZeneca #Oxford #SerumInstituteOfIndia #SII #India #ChAdOx1 #Interview #Video

SII CEO Adar Poonawalla Exclusive On Covishield Vaccine Pricing, Production & Much More | CNBC TV18

YouTube